Compare CSV & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSV | DRTS |
|---|---|---|
| Founded | 1991 | 2015 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 678.1M | 607.1M |
| IPO Year | 1996 | N/A |
| Metric | CSV | DRTS |
|---|---|---|
| Price | $44.13 | $7.12 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $59.00 | $8.00 |
| AVG Volume (30 Days) | 77.2K | ★ 367.3K |
| Earning Date | 02-25-2026 | 11-20-2025 |
| Dividend Yield | ★ 1.02% | N/A |
| EPS Growth | ★ 38.46 | N/A |
| EPS | ★ 3.09 | N/A |
| Revenue | ★ $409,658,000.00 | N/A |
| Revenue This Year | $3.81 | N/A |
| Revenue Next Year | $3.37 | N/A |
| P/E Ratio | $14.24 | ★ N/A |
| Revenue Growth | ★ 1.07 | N/A |
| 52 Week Low | $35.51 | $2.30 |
| 52 Week High | $49.41 | $7.89 |
| Indicator | CSV | DRTS |
|---|---|---|
| Relative Strength Index (RSI) | 58.78 | 67.80 |
| Support Level | $42.92 | $6.45 |
| Resistance Level | $44.62 | $5.14 |
| Average True Range (ATR) | 1.27 | 0.54 |
| MACD | 0.16 | 0.17 |
| Stochastic Oscillator | 82.73 | 75.64 |
Carriage Services Inc is a provider of funeral and cemetery services and merchandise in the United States. It operates in two business segments: The Funeral Home Operations segment offers burial, cremation, and consultation services; removes and prepares remains; sells caskets, urns, and related funeral merchandise; and enables the use of funeral home facilities for visitation, remembrance, and transportation services. The Cemetery Operations segment provides services, such as mausoleum spaces and niches, private estates, lawn crypt gardens, traditional single burial gravesites, and burial vaults. The majority of revenue is derived from The Funeral Home Operations segment.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.